A new programme at the US Department of Defense funds regenerative medicine to help wounded vets, but a surprising level of detail seems top secret!
“As expected of a programme that has the enthusiastic support of the Bush administration, AFIRM will steer clear of embryonic stem (ES) cells. Since the technologies are supposed to be moving quickly towards clinical trials, Vandre says embryonic stem cell technologies would not likely be applicable even in a more favorable political environment. Many are not far enough along in development to meet time constraints. Though AFIRM plans to use some placental or amniotic fluid stem cells, most projects rely on cells taken from the patients themselves, thus sidestepping issues of tissue rejection.”
- Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.